Capricor’s HOPE-3 Extension Shows 76% Slower Arm Decline in DMD, but Analysts Still Expect an FDA Rejection

New Capricor extension data support slower DMD arm decline, but H.C. Wainwright and Roth still see a complete response letter as more likely.